Exparel (bupivacaine liposomal) is a brand-name drug prescribed for pain relief after surgery in adults and some children. Exparel comes as an injection that’s given as a single dose by a healthcare ...
Pacira BioSciences, Inc. (NASDAQ: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients, today announced that ...
Results Presented at the 2015 Annual Meeting of the American Academy of Orthopedic Surgeons Find Overall Hospital Cost Savings of More Than $1.5 Million Pacira Pharmaceuticals, Inc. (NASDAQ: PCRX) ...
Zacks.com on MSN
PCRX's Exparel Wins Separate Reimbursement From UnitedHealthcare
Pacira BioSciences PCRX has announced that UnitedHealthcare, the largest U.S. health insurer with about 40 million members, ...
According to the American College of Surgeons, 15 million Americans undergo surgery each year. Despite this high frequency and the significant impact these procedures can have on patients, no ...
BRISBANE, Calif., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX), the industry leader in the delivery of innovative, non-opioid pain therapies to transform the lives of ...
— EXPAREL is the only FDA-approved single-dose regional analgesic to safely demonstrate four days of superiority versus bupivacaine in two clinical studies — — New indications for use as an adductor ...
Exparel (bupivacaine liposome injectable suspension) is prescribed for pain relief after surgery. The drug comes as a suspension. A healthcare professional injects this type of liquid mixture as a one ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results